Navellier & Associates’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,553
Closed -$373K 332
2021
Q4
$373K Buy
7,553
+373
+5% +$20.7K 0.05% 245
2021
Q3
$511K Buy
+7,180
New +$446K 0.08% 190
2014
Q2
Sell
-7,065
Closed -$271K 350
2014
Q1
$271K Buy
+7,065
New +$228K 0.01% 270

Other funds holding PRTA

Navellier & Associates's PRTA Position: Q1 2022 in Review

Navellier & Associates sold out of Prothena Corp (PRTA) in Q1 2022, closing a stake of 7,553 shares — an estimated $373K sold.

Navellier & Associates first reported a position in PRTA in Q1 2014 and held it in 3 quarters. The position peaked at $511K in Q3 2021. 174 funds tracked by Wall St. Rank hold PRTA as of Q1 2022.

  • Navellier & Associates reported no remaining Prothena Corp position as of Q1 2022 after selling out during the quarter.
  • Navellier & Associates sold 7,553 Prothena Corp shares in Q1 2022, an estimated $373K.
  • Navellier & Associates first reported a position in Prothena Corp in Q1 2014 and held it in 3 quarters.
  • Navellier & Associates's Prothena Corp position peaked at $511K in Q3 2021.
  • 174 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2022.

Based on Navellier & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.